swissTB award 2012
Dr. Alexandre Harari
Publikation
Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease.
Alexandre Harari1,2, Virginie Rozot1, Felicitas Bellutti Enders1, Matthieu Perreau1, Jesica Mazza Stalder3, Laurent P Nicod3, Matthias Cavassini4, Thierry Calandra4, Catherine Lazor Blanchet4, Katia Jaton6, Mohamed Faouzi7, Cheryl L Day8, Willem A Hanekom8, Pierre-Alexandre Bart1 & Giuseppe Pantaleo1,2
1Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland. 2Swiss Vaccine Research Institute, Lausanne, Switzerland. 3Division of Pneumology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland. 4Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland. 5Division of Occupational Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland. 6Institute of Microbiology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland. 7Center of Clinical Epidemiology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland. 8South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town, South Africa.© 2011 Nature America, Inc. All rights reserved.